-
Danish Pharmacovigilance Update, February 2015
| 16 March 2015 |
The February issue of Danish Pharmacovigilance Update with news from the EU, the DHMA and short news.
-
Danish Pharmacovigilance Update, January 2015
| 10 February 2015 |
The January issue of Danish Pharmacovigilance Update with news from the EU, the DHMA and short news.
-
Danish Pharmacovigilance Update, December 2014
| 12 January 2015 |
The December issue of Danish Pharmacovigilance Update with news from the EU, the DHMA and short news.
-
Danish Pharmacovigilance Update, November 2014
| 02 December 2014 |
Five years ago, we issued Danish Pharmacovigilance Update for the first time. We are delighted to celebrate the newsletter's fifth anniversary with more than 3,000 subscribers to the Danish and the English version, and we hope the interest in Danish Pharmacovigilance Update will continue to grow. You can sign up for the newsletter on our website under News. Among the articles in this issue, you can read about how we have developed the pharmacovigilance activities in the recent years.
-
Danish Pharmacovigilance Update, October 2014
| 11 November 2014 |
Read the October issue of Danish Pharmacovigilance Update.
-
Danish Pharmacovigilance Update, September 2014
| 07 October 2014 |
The September issue of Danish Pharmacovigilance Update.
-
Danish Pharmacovigilance Update, August 2014
| 09 September 2014 |
The August issue of Danish Pharmacovigilance Update.
-
Danish Pharmacovigilance Update June 2014
| 17 July 2014 |
The June issue of Danish Pharmacovigilance Update.
-
Danish Pharmacovigilance Update May 2014
| 14 July 2014 |
In the May issue of Danish Pharmacovigilance Update: Assessment of risk of serious anaphylactic reactions from treatment with ferumoxytol (Rienso), ADR reports for the HPV vaccine and the Danish Health and Medicines Authority’s annual pharmacovigilance report 2013.
-
Danish Pharmacovigilance Update 30 April 2014
| 07 May 2014 |
In the April issue of Danish Pharmacovigilance Update:
-
Danish Pharmacovigilance Update 29 January 2014
| 14 April 2014 |
In this issue of Danish Pharmacovigilance Update
-
Danish Pharmacovigilance Update 27 March 2014
| 10 April 2014 |
In this issue of Danish Pharmacovigilance Update
-
Danish Pharmacovigilance Update 27 February 2014
| 01 April 2014 |
In this issue of Danish Pharmacovigilance Update: Further restrictions on the use of osteoporosis medicine strontium ranelate (Protelos®), Anticoagulant therapy to be stopped before initiating treatment with the new oral anticoagulants (NOACs).
-
Danish Pharmacovigilance Update 31 October 2013
| 05 March 2014 |
In this issue of Danish Pharmacovigilance Update: The risk of blood clots from the use of contraceptive pills is low regardless of type, Report of cardiac arrest in association with the use of flecainide (Tambocor®).
-
Danish Pharmacovigilance Update 19 December 2013
| 17 February 2014 |
In this issue of Danish Pharmacovigilance Update: Patients with mechanical heart valves should not be treated with the new oral anticoagulants Pradaxa®, Xarelto® and Eliquis®.
-
Danish Pharmacovigilance Update 28 November 2013
| 03 February 2014 |
In this issue of Danish Pharmacovigilance Update: Ciprofloxacin and the risk of tendon disorders, risk of blood clots from the use of the cancer medicine ponatinib and reporting of adverse reactions to the Danish Health and Medicines Authority.
-
Danish Pharmacovigilance Update, 26 September 2013
| 21 November 2013 |
In this issue of Danish Pharmacovigilance Update: Filgrastim (Neupogen) and pegfilgrastim (Neulasta) are associated with risk of capillary leak syndrome.
-
Danish Pharmacovigilance Update, 29 August 2013
| 23 October 2013 |
In this issue of Danish Pharmacovigilance Update: Cases of acquired haemophilia following treatment with clopidogrel (Plavix® etc.)
-
Danish Pharmacovigilance Update, 27 June 2013
| 24 July 2013 |
In this issue of Danish Pharmacovigilance Update: The benefits of medicines for the treatment of acne (Diane® Mite and others) continue to outweigh the risks of use within the indication.
-
Voluntary Harmonisation Procedure (VHP) for the assessment of multinational clinical trial applications
| 09 July 2013 |
The Voluntary Harmonisation Procedure is a procedure which makes it possible to obtain a coordinated assessment of an application for a clinical trial that is to take place in several European countries.
